Welcome to the Transplantation Learning Zone, an online resource intended to educate healthcare professionals in best practice for the transplantation of various organs.
This Learning Zone covers the indications for transplantation, discussing the most common conditions resulting in organ failure; epidemiology, providing global statistics for organ donation and transplantation, the burden of disease and complication rates; the surgical techniques used, supported by current guideline recommendations; the various methods for immunosuppression, such as calcineurin inhibitors, induction therapy and anti-metabolites; long-term outcomes, discussing the causes of mortality and exploring the options for improvement; and finally, future developments, evaluating the use of regenerative medicine and organs grown ex vivo.
In addition, slide and video presentations are available from the 18th Congress of the European Society for Organ Transplantation (ESOT) in 2019 & 2017 and the 27th meeting of The Transplantation Society (TTS) in 2018. These resources discuss the latest clinical research data for kidney and liver transplantation.
Read about the Indications, Epidemiology and Immunosuppression in solid organ transplantation, the long-term outcomes and complications of transplantation, including future developments on the horizon.
Learn about the data presented at key congresses such as ESOT 2019, 2017 and TTS 2018.
Find out more about the key candidate organs for transplantation, from kidney, liver, heart and lung to others such as the pancreas, intestine, cornea and haematopoietic stem cells.
Read more about the epidemiology of transplantation. How are suitable candidates selected? How many living and deceased donors are there? What are the complication rates?
Learn more about the surgical procedures for transplantation. How they are constantly evolving and what guidelines and studies endorse as best practice.
Discover the wide range of pharmacological immunosuppressive methods available, such as calcineurin inhibitors, mTOR inhibitors, anti-metabolites and biologic agents, alongside typical treatment regimens.
Learn why transplantation is now recognised as the best therapy for end-stage organ failure, improving quality of life and life expectancy. However, significant morbidities remain and require improvement.
Explore the future developments in organ transplantation, designed to minimise graft failure and improve the availability of organs suitable for transplantation.
Alternatively login via
Back to epgonline.org